<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0200269.ref055">
 <label>55</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Patel</surname>
   <given-names>EU</given-names>
  </name>, 
  <name>
   <surname>Cox</surname>
   <given-names>AL</given-names>
  </name>, 
  <name>
   <surname>Mehta</surname>
   <given-names>SH</given-names>
  </name>, 
  <name>
   <surname>Boon</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Mullis</surname>
   <given-names>CE</given-names>
  </name>, 
  <name>
   <surname>Astemborski</surname>
   <given-names>J</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection</article-title>. 
  <source>J Infect Dis</source>. 
  <year>2016</year>;
  <volume>214</volume>(
  <issue>3</issue>):
  <fpage>344</fpage>â€“
  <lpage>52</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jiw005</pub-id> ; PubMed Central PMCID: PMCPMC4936640.
  <?supplied-pmid 26768250?>
  <pub-id pub-id-type="pmid">26768250</pub-id>
 </mixed-citation>
</ref>
